Breathing New Insights: Case Study on Asthma and COPD Asset Assessment Through Conference Intelligenc

Objective: Charting the AIR Landscape of Asthma & COPD Assets

In the rapidly evolving respiratory therapy domain, stakeholders need clear, up-to-date intelligence on the assets for Asthma and Chronic Obstructive Pulmonary Disease (COPD). This case study by DelveInsight focuses on the conference-coverage mechanism applied to respiratory assets: to map, track and assess asthma and COPD therapeutic programmes presented at major scientific meetings. The objective is to enable AIR teams to grasp which assets are advancing, how the therapy space is shifting and where the investment and competitive opportunities lie.

Problem Statement: Bridging the Gap Between Conference Noise and AIR Actionable Intelligence

While numerous abstracts, posters and presentations emerge from respiratory therapy conferences each year, AIR teams are often overwhelmed by volume and lack the structured intelligence to translate content into strategic insight. The problem: Without systematic conference coverage intelligence, companies risk missing emerging assets, pipeline shifts or competitor signals in the asthma-COPD intersection. DelveInsight identified this gap for therapy area functions needing curated, timely insight from conference venues into asthma and COPD asset landscapes.

Our Methodology: DelveInsight’s Conference Coverage Framework for Respiratory Assets

DelveInsight leverages its established conference-coverage platform (as articulated on their ATS and respiratory domain pages). For this case study, the methodology included: pre-conference planning (defining asthma and COPD asset watch-lists), live tracking of respiratory therapy sessions (abstracts, posters, late breaker data) and post-conference analysis (asset deep-dives, competitive benchmarking, pipeline implications). The focus was specifically on AIR (Asthma, Inspired-respiratory, Respiratory therapy) assets: novel inhaled, biologic or device treatments for asthma and COPD. Through this disciplined approach, DelveInsight aggregated and prioritized assets, mapped shifting therapy landscapes and produced actionable insight for respiratory therapy teams.

Results: From Data to Insight: Highlights for AIR Teams

Results of the case study show that DelveInsight not only captured hundreds of relevant abstracts but distilled them into a clear dashboard of major asthma and COPD assets moving through trials, presentation trends and competitive positioning (as evident in their respiratory therapy blogs). For AIR teams this meant: faster identification of high-impact assets, clearer visibility of cross-indication movement (asthma - COPD), and stronger foundation for strategic decisions (licensing, portfolio prioritisation, region-specific launch readiness). In sum, the case study demonstrates how DelveInsight turns conference output into structured AIR asset intelligence.

In conclusion, this case-study underscores the value of conference coverage intelligence in the asthma and COPD therapy area. By partnering with DelveInsight, respiratory therapy (AIR) teams can unlock deeper insight, reduce noise and sharpen their asset and market strategies.